WP6 - Functional imaging platform
Objectives
- Assessment of combined functional imaging (FDG-PET, metomidate tracers) as a tool to noninvasively characterize potentially malignant adrenocortical masses
- Evaluation of FDG-PET scanning to predict treatment response in patients with MPH in the context of the FIRSTMAPPP trial
WP Leader
Prof. Bruno Allolio, 
University Hospital of Würzburg
WP Partners
Ludwig-Maximilians-University Munich
